A detailed history of Salomon & Ludwin, LLC transactions in Organon & Co. stock. As of the latest transaction made, Salomon & Ludwin, LLC holds 109 shares of OGN stock, worth $1,740. This represents 0.0% of its overall portfolio holdings.

Number of Shares
109
Previous 141 22.7%
Holding current value
$1,740
Previous $2,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

SELL
$18.65 - $23.03 $596 - $736
-32 Reduced 22.7%
109 $2,000
Q2 2024

Jul 25, 2024

SELL
$17.45 - $21.96 $2,896 - $3,645
-166 Reduced 54.07%
141 $2,000
Q1 2024

May 02, 2024

SELL
$13.78 - $18.8 $2,935 - $4,004
-213 Reduced 40.96%
307 $5,000
Q3 2023

Nov 13, 2023

BUY
$16.59 - $23.77 $8,626 - $12,360
520 New
520 $9,000

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $4.06B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track Salomon & Ludwin, LLC Portfolio

Follow Salomon & Ludwin, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Salomon & Ludwin, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Salomon & Ludwin, LLC with notifications on news.